comparemela.com

Bone Marrow Transplantation Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OncLive December Recap: FDA Approval Highlights

Final APPLY-PNH Data Support Use of Iptacopan in PNH With Persistent Anemia

Oral iptacopan (Fabhalta) monotherapy induced durable responses and hemolysis control in patients with paroxysmal nocturnal hemoglobinuria and persistent anemia who had previously received anti-C5 treatment.

Burjeel Medical City and UK-based Digipharm Collaborate to Improve Access to Value-based Healthcare

To provide the best advanced health technologies and create an enhanced end-to-end patient experience, Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, and Digipharm, a UK-based innovative healthcare solutions provider, have joined hands to design and validate a new model for patient care in the UAE.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.